Aberrant expression of intestinal mucin antigens associated with colorectal carcinoma defined by a panel of monoclonal antibodies
1991

Study of Mucin Antigens in Colorectal Cancer

Sample size: 100 publication Evidence: moderate

Author Information

Author(s): P.J. Hertzog, S.J. Pilbrow, J. Pedersen, A.L. Polglase, M. Lawson, A.W. Linnane

Primary Institution: Monash University

Hypothesis

The study aims to characterize altered mucin expression in colorectal adenocarcinomas using monoclonal antibodies.

Conclusion

The study found that altered mucin glycoprotein metabolism is associated with the development and progression of most colorectal cancers.

Supporting Evidence

  • All mucin monoclonal antibodies reacted with a high proportion of the 100 colon cancers.
  • 85% of early stage cancers showed inappropriate SIMA production.
  • Altered mucin expression was detected in both cancerous and adjacent normal tissues.

Takeaway

Researchers looked at special proteins in cancer cells from the colon and found that many of them were different from normal cells, which could help in detecting cancer early.

Methodology

The study used immunohistochemistry and quantitative immunoassays to analyze mucin expression in tissue samples from colorectal cancer patients.

Limitations

The study did not establish strict correlations between mucin antigen reactivity and specific clinicopathological parameters.

Participant Demographics

53 females and 45 males, mean age 70 years for females and 66 years for males.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication